Tabrecta

Tabrecta Indications/Uses

capmatinib

Manufacturer:

Distributor:

Zuellig

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

TABRECTA is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping.

Continue with Google

Already a member? Sign in

Tabrecta Indications/Uses

capmatinib

Manufacturer:

Novartis

Distributor:

Zuellig